Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs

Journal of Applied Physiology

Volumn 95, Issue 4, 2003, Pages 1688-1694

  Post, Heiner ^a   Kajstura, Jan ^a   Lei, Biao ^a   Sessa, William C ^b   Byrne, Barry ^c   Anversa, Piero ^a   Hintze, Thomas H ^a   Recchia, Fabio A ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Green fluorescent protein; Hemodynamics; Von Willebrand factor; White cells

Indexed keywords

GREEN FLUORESCENT PROTEIN; VON WILLEBRAND FACTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY BLOOD VESSEL; DOG; GENETIC TRANSFECTION; HEART LEFT VENTRICLE PRESSURE; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM;

EID: 0141566923     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00896.2002     Document Type: Article

References (29)

1. Arnold TE, Gnatenko D, and Bahou WF. In vivo gene transfer into rat arterial walls with novel adeno-associated virus vectors. J Vasc Surg 25: 347-355, 1997.
2. Berns KI and Linden RM. The cryptic life style of adeno-associated virus. Bioessays 17: 237-245, 1995.
3. Brockstedt DG, Podsakoff GM, Fong L, Kurtzman G, Mueller-Ruchholtz W, and Engleman EG. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration. Clin Immunol 92: 67-75, 1999.
4. Brush JE Jr, Cannon RO, Schenke WH III, Bonow RO, Leon MB, Maron BJ, and Epstein SE. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319: 1302-1307, 1988.
5. Conway JE, Rhys CM, Zolotukhin I, Zolotukhin S, Muzyczka N, Hayward GS, and Byrne BJ. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap. Gene Ther 6: 986-993, 1999.
6. Gnatenko D, Arnold TE, Zolotukhin S, Nuovo GJ, Muzyczka N, and Bahou WF. Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into endothelial cells. J Investig Med 45: 87-98, 1997.
7. Hajjar RS, Del Monte F, Matsui T, and Rosenzweig A. Prospects for gene therapy for heart failure. Circ Res 86: 616-621, 2000.
8. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, and High KA. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 5: 56-63, 1999.
9. Kaplitt MG, Xiao X, Samulski RJ, Li J, Ojamaa K, Klein IL, Makimura H, Kaplitt MJ, Strumpf RK, and Diethrich EB. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg 62: 1669-1676, 1996.
10. Kay MA, Glorioso JC, and Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 7: 33-40, 2001.
11. Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, and Byrne BJ. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 93: 14082-14087, 1996.
12. Kullo IJ, Simari RD, and Schwartz RS. Vascular gene transfer: from bench to bedside. Arterioscler Thromb Vasc Biol 19: 196-207, 1999.
13. Lynch CM, Hara PS, Leonard JC, Williams JK, Dean RH, and Geary RL. Adeno-associated virus vectors for vascular gene delivery. Circ Res 80: 497-505, 1997.
14. Marban E. Gene therapy for common acquired diseases of the heart. The Siren's Song. Circulation 101: 1498-1499, 2000.
15. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet SF, Layne MD, Perrella MA, and Dzau VJ. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105: 602-607, 2002.
16. Nahser PJ Jr, Brown RE, Oskarsson H, Winniford MD, and Rossen JD. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91: 635-640, 1995.
17. Paulus WJ, Vantrimpont PJ, and Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 92: 2119-2126, 1995.
18. Richter M, Iwata A, Nyhuis J, Nitta Y, Miller AD, Halbert CL, and Allen MD. Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. Physiol Genomics 2: 117-127, 2000.
19. Rolling F, Nong Z, Pisvin S, and Collen D. Adeno-associated virus-mediated gene transfer into rat carotid arteries. Gene Ther 4: 757-761, 1997.
20. Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, and Dichek DA. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler Thromb 14: 148-161, 1994.
21. Schachinger V, Britten MB, and Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899-1906, 2000.
22. Shen W, Lundborg M, Wang J, Stewart JM, Xu X, Ochoa M, and Hintze TH. Role of EDRF in the regulation of regional blood flow and vascular resistance at rest and during exercise in conscious dogs. JAppl Physiol 77: 165-172, 1994.
23. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, Colucci WS, Sutton MG, Selwyn AP, and Alexander RW. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 81: 772-779, 1990.
24. Verma S and Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation 105: 546-549, 2002.
25. Wang J, Seyedi N, Xu XB, Wolin MS, and Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. Am J Physiol Heart Circ Physiol 266: H670-H680, 1994.
26. Wright MJ, Wightman LM, Lilley C, de Alwis M, Hart SL, Miller A, Coffin RS, Thrasher A, Latchman DS, and Marber MS. In vivo myocardial gene transfer: optimization, evaluation and direct comparison of gene transfer vectors. Basic Res Cardiol 96: 227-236, 2001.
27. Xiao X, Li J, and Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70: 8098-8108, 1996.
28. Xu L, Daly T, Gao C, Flotte TR, Song S, Byrne BJ, Sands MS, and Parker PK. CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum Gene Ther 12: 563-573, 2001.
29. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, and Muzyczka N. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 6: 973-985, 1999.